Back

Impact of thrombocytopenia on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT Study

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Venous thromboembolism Venous Thromboembolism ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yutaro Miyoshi

Kyoto University Graduate School of Medicine, Kyoto (Japan)

7 More presentations in this session

Presentation thumbnail
Impact of reasons for discontinuing anticoagulation therapy on clinical outcomes in patients with venous thromboembolism: insight from the COMMAND VTE Registry-2
Doctor M. Kinugawa (Toyonaka, JP)
Abstract Slides Video
Presentation thumbnail
Statin therapy for the prevention of venous thromboembolism in cancer patients: a systematic review and meta-analysis
Doctor F. Catalani (Bellinzona, CH)
Abstract Slides Video
Presentation thumbnail
The predictive value of estimated glucose disposal rate for the risk of venous thromboembolism in elderly individuals: a prospective cohort study of UK biobank
Doctor Y. Zheng (Tianjin, CN) Doctor T. Liu (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Comparison of hospital and home treatment for symptomatic proximal deep vein thrombosis: from theCOMMAND VTE Registry-2
Mr K. Mushiake (Kurashiki, JP)
Abstract Slides Video
Presentation thumbnail
Has post-COVID-19 increased CTEPD rates? A prospective study on persistent dyspnea and risk factors
Doctor L. Alajbegovic (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Venous thromboembolism

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of prolonged edoxaban treatment for gastrointestinal cancer patients with isolated distal deep vein thrombosis: insight from the ONCO DVT study
thumbnail
Congress Presentation
Efficacy and safety of long-term edoxaban treatment for low body weight cancer patients with isolated distal deep vein thrombosis: a post-hoc subgroup analysis of the ONCO DVT study
thumbnail
Congress Presentation
ONCO DVT Study; Optimal duration of anticoagulation therapy for isolated distal deep vein thrombosis in patients with cancer study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources